Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1957 1
1958 1
1960 1
1964 1
1965 1
1966 1
1968 1
1969 1
1970 4
1971 3
1972 12
1973 19
1974 22
1975 64
1976 67
1977 57
1978 85
1979 88
1980 132
1981 96
1982 119
1983 126
1984 195
1985 213
1986 229
1987 235
1988 255
1989 363
1990 385
1991 373
1992 461
1993 484
1994 527
1995 547
1996 596
1997 701
1998 770
1999 815
2000 958
2001 1010
2002 1064
2003 1189
2004 1258
2005 1381
2006 1509
2007 1538
2008 1791
2009 1813
2010 2280
2011 2532
2012 2915
2013 3169
2014 3510
2015 3943
2016 4064
2017 4371
2018 4748
2019 5077
2020 5919
2021 6631
2022 6418
2023 6429
2024 6541
2025 117

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

81,235 results

Results by year

Filters applied: . Clear all
Page 1
Breast Cancer Epidemiology, Prevention, and Screening.
Winters S, Martin C, Murphy D, Shokar NK. Winters S, et al. Prog Mol Biol Transl Sci. 2017;151:1-32. doi: 10.1016/bs.pmbts.2017.07.002. Epub 2017 Oct 10. Prog Mol Biol Transl Sci. 2017. PMID: 29096890 Review.
Globally, breast cancer is both the most commonly occurring cancer and the commonest cause of cancer death among women. ...This pattern is likely to be due to changing risk factor profiles and differences in access to breast cancer early …
Globally, breast cancer is both the most commonly occurring cancer and the commonest cause of cancer death among …
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer.
Li X, Yang J, Peng L, Sahin AA, Huo L, Ward KC, O'Regan R, Torres MA, Meisel JL. Li X, et al. Breast Cancer Res Treat. 2017 Jan;161(2):279-287. doi: 10.1007/s10549-016-4059-6. Epub 2016 Nov 25. Breast Cancer Res Treat. 2017. PMID: 27888421
We examined the prognosis of triple-negative breast cancer (TNBC) versus non-TNBC within the same stages and sub-stages to evaluate whether TNBC had worse prognosis than non-TNBC. ...The new AJCC staging manual should consider breast cancer biom …
We examined the prognosis of triple-negative breast cancer (TNBC) versus non-TNBC within the same stages and sub-stages …
Breast Cancer: Current Molecular Therapeutic Targets and New Players.
Nagini S. Nagini S. Anticancer Agents Med Chem. 2017;17(2):152-163. doi: 10.2174/1871520616666160502122724. Anticancer Agents Med Chem. 2017. PMID: 27137076 Review.
Breast cancer is the most common cancer and the most frequent cause of cancer death among women worldwide. Breast cancer is a complex, heterogeneous disease classified into hormone-receptor-positive, human epidermal growth factor receptor …
Breast cancer is the most common cancer and the most frequent cause of cancer death among women worldwide. Br …
Screening for breast cancer in 2018-what should we be doing today?
Seely JM, Alhassan T. Seely JM, et al. Curr Oncol. 2018 Jun;25(Suppl 1):S115-S124. doi: 10.3747/co.25.3770. Epub 2018 Jun 13. Curr Oncol. 2018. PMID: 29910654 Free PMC article. Review.
To help oncologists and physicians provide optimal patient recommendations, the literature was reviewed to find the latest guidelines for screening mammography, including benefits and perceived harms of overdiagnosis, false positives, false negatives, and technologic advan …
To help oncologists and physicians provide optimal patient recommendations, the literature was reviewed to find the latest guidelines for sc …
BREAST CANCER IN YOUNG WOMEN: PATHOLOGIC AND IMMUNOHISTOCHEMICAL FEATURES.
Erić I, Petek Erić A, Kristek J, Koprivčić I, Babić M. Erić I, et al. Acta Clin Croat. 2018 Sep;57(3):497-502. doi: 10.20471/acc.2018.57.03.13. Acta Clin Croat. 2018. PMID: 31168183 Free PMC article.
- A young woman with breast cancer is considered to be a woman younger than 40. According to the literature, breast cancer in the population of young women usually is of a higher histologic grade, unfavorable hormonal status, and overall higher mortali …
- A young woman with breast cancer is considered to be a woman younger than 40. According to the literature, breast …
Triple-negative breast cancer: an unmet medical need.
Hudis CA, Gianni L. Hudis CA, et al. Oncologist. 2011;16 Suppl 1:1-11. doi: 10.1634/theoncologist.2011-S1-01. Oncologist. 2011. PMID: 21278435 Free article. Review.
The metastatic potential in triple-negative breast cancer is similar to that of other breast cancer subtypes, but these tumors are associated with a shorter median time to relapse and death. ...Triple-negative breast cancer …
The metastatic potential in triple-negative breast cancer is similar to that of other breast cancer subty …
Bioinformatics analysis of prognostic significance of COL10A1 in breast cancer.
Zhang M, Chen H, Wang M, Bai F, Wu K. Zhang M, et al. Biosci Rep. 2020 Feb 28;40(2):BSR20193286. doi: 10.1042/BSR20193286. Biosci Rep. 2020. PMID: 32043519 Free PMC article.
The relationship between COL10A1 expression level and clinical indicators including prognostic data in breast cancer were analyzed by the Kaplan-Meier Plotter, PrognoScan, and Breast Cancer Gene-Expression Miner (bc-GenExMiner) databases. ...Conversely …
The relationship between COL10A1 expression level and clinical indicators including prognostic data in breast cancer were anal …
Therapeutic delivery of siRNA for the management of breast cancer and triple-negative breast cancer.
Sai BM, Dinakar YH, Kumar H, Jain R, Kesharwani S, Kesharwani SS, Mudavath SL, Ramkishan A, Jain V. Sai BM, et al. Ther Deliv. 2024;15(11):871-891. doi: 10.1080/20415990.2024.2400044. Epub 2024 Sep 25. Ther Deliv. 2024. PMID: 39320858 Review.
Nanoparticulate systems such as polymeric, lipid, lipid-polymeric, metallic, mesoporous silica nanoparticles and several other nanocarriers were used for effective delivery of siRNA and to knock down genes involved in breast cancer and triple-negative brea …
Nanoparticulate systems such as polymeric, lipid, lipid-polymeric, metallic, mesoporous silica nanoparticles and several other nanocarriers …
Editorial: The Androgen Receptor in Breast Cancer.
Tesei A, Castoria G. Tesei A, et al. Front Endocrinol (Lausanne). 2021 Jan 15;11:636480. doi: 10.3389/fendo.2020.636480. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33519718 Free PMC article. No abstract available.
Prognostic impact of PTK6 expression in triple negative breast cancer.
Chen Y, Qu W, Tu J, Yang L, Gui X. Chen Y, et al. BMC Womens Health. 2023 Nov 7;23(1):575. doi: 10.1186/s12905-023-02736-y. BMC Womens Health. 2023. PMID: 37932734 Free PMC article.
BACKGROUND: The aim of this study was to investigate the expression of PTK6 in different groups of triple negative breast cancer and its impact on prognosis. METHODS: Retrospective study of a total of 209 surgical specimens of breast cancer were …
BACKGROUND: The aim of this study was to investigate the expression of PTK6 in different groups of triple negative breast c …
81,235 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "negative breast cancer"